milnacipran has been researched along with vortioxetine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deardorff, WJ; Grossberg, GT | 1 |
| Roman, MW; Wilkinson, SM | 1 |
| Citrome, L | 1 |
| Bundgaard, C; Eneberg, E; Sánchez, C | 1 |
| Abdool, PS; Mulsant, BH; Patel, K; Rajji, TK | 1 |
| An, X; Fan, Y; Guo, L; He, H; Lyu, J; Ma, X; Wang, W; Zheng, J | 1 |
| Gartlehner, G; Klerings, I; Schultes, MT; Teufer, B; Titscher, V; Wagner, G | 1 |
5 review(s) available for milnacipran and vortioxetine
| Article | Year |
|---|---|
A review of the clinical efficacy, safety and tolerability of the antidepressants vilazodone, levomilnacipran and vortioxetine.
Topics: Antidepressive Agents; Benzofurans; Clinical Trials, Phase III as Topic; Cyclopropanes; Depressive Disorder, Major; Humans; Indoles; Milnacipran; Piperazines; Sulfides; Vilazodone Hydrochloride; Vortioxetine | 2014 |
Vortioxetine (Brintellix®) and levomilnacipran (Fetzima®): the two newest additions to the antidepressant formulary.
Topics: Antidepressive Agents; Cyclopropanes; Depressive Disorder, Major; Drug Approval; Humans; Milnacipran; Piperazines; Sulfides; United States; United States Food and Drug Administration; Vortioxetine | 2014 |
Pharmacotherapy of major depression in late life: what is the role of new agents?
Topics: Antidepressive Agents; Cyclopropanes; Depressive Disorder, Major; Humans; Milnacipran; Piperazines; Randomized Controlled Trials as Topic; Sulfides; Vilazodone Hydrochloride; Vortioxetine | 2017 |
Efficacy and tolerability of different doses of three new antidepressants for treating major depressive disorder: A PRISMA-compliant meta-analysis.
Topics: Antidepressive Agents; Cyclopropanes; Depressive Disorder, Major; Humans; Milnacipran; Piperazines; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sulfides; Vilazodone Hydrochloride; Vortioxetine | 2018 |
Efficacy and safety of levomilnacipran, vilazodone and vortioxetine compared with other second-generation antidepressants for major depressive disorder in adults: A systematic review and network meta-analysis.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclopropanes; Depressive Disorder, Major; Humans; Milnacipran; Network Meta-Analysis; Piperazines; Sulfides; Vilazodone Hydrochloride; Vortioxetine | 2018 |
2 other study(ies) available for milnacipran and vortioxetine
| Article | Year |
|---|---|
Vilazodone, levomilnacipran and vortioxetine for major depressive disorder: the 15-min challenge to sort these agents out.
Topics: Antidepressive Agents; Cyclopropanes; Depressive Disorder, Major; Humans; Milnacipran; Piperazines; Sulfides; Vilazodone Hydrochloride; Vortioxetine | 2015 |
P-glycoprotein differentially affects escitalopram, levomilnacipran, vilazodone and vortioxetine transport at the mouse blood-brain barrier in vivo.
Topics: Animals; Antidepressive Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Blood-Brain Barrier; Brain Chemistry; Cerebral Cortex; Citalopram; Cyclopropanes; Male; Mice; Milnacipran; Piperazines; Serotonin Plasma Membrane Transport Proteins; Sulfides; Vilazodone Hydrochloride; Vortioxetine | 2016 |